Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples